Modified Neck Dissection for Metastatic Testicular Carcinoma

Richard D. Zeph, Edward C. Weisberger, Lawrence H. Einhorn, Stephen D. Williams, Raleigh E. Lingeman

Research output: Contribution to journalArticle

9 Scopus citations


Carcinoma of the testicle is a unique clinicopathologic entity in that an optimistic attitude toward cure can be entertained even in the presence of distant metastasis. Chemotherapy, followed by an aggressive surgical resection of residual disease, can result in eradication of this neoplasm. This tumor is capable of being monitored by the use of serum markers, namely, human chorionic gonadotropin and α-fetoprotein. After induction chemotherapy, the transition of elevated serum tumor markers to normal levels suggests that malignant disease has been eliminated or converted to teratoma. Elevated markers indicate persistent or recurrent carcinoma and mandate further chemotherapy. If normalization of tumor markers occurs, any residual mass in the abdomen, chest, or neck should be surgically resected. The otolaryngologist plays a role in the diagnosis and the resection of residual neck disease. Metastatic testicular carcinoma can present as a supraclavicular neck mass and must be considered in the differential diagnosis of a mass in this area. Large residual neck lesions are best removed through the exposure afforded by modified neck dissection. (Arch Otolaryngol 1985;111:667-672)

Original languageEnglish (US)
Pages (from-to)667-672
Number of pages6
JournalArchives of Otolaryngology
Issue number10
StatePublished - Oct 1985
Externally publishedYes

ASJC Scopus subject areas

  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Modified Neck Dissection for Metastatic Testicular Carcinoma'. Together they form a unique fingerprint.

  • Cite this